Revenue segments as reported by the company.

Clearing and transaction fees

Market data and information services

Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Compensation and benefits  

Technology

Professional fees and outside services

Amortization of purchased intangibles

Depreciation and amortization

Licensing and other fee agreements

Other expenses

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CME Group

CME Group, Inc. operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals. It offers futures and options on futures trading across asset classes through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it also operates CME Clearing, a central counterparty clearing provider. The company was founded in 1898 and is headquartered in Chicago, IL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CME Group achieves record-breaking 2022 performance amidst market challenges

CME Group's 2022 performance was exceptional, marked by record volumes, revenue growth, and successful transitions. The company's focus on innovation, strategic positioning in energy and cryptocurrency markets, and pricing adjustments have driven positive outcomes. Challenges in margins and market uncertainties require careful navigation.

CME Group posts record Q1 earnings, eyes growth in SOFR

CME Group delivered a strong performance in Q1 2023, achieving record revenue and profitability driven by growth in interest rate and options trading.
The company's strategic focus on risk management, shareholder value creation, and market competitiveness positions it well for future growth and revenue generation.
While facing challenges in a competitive market environment, CME Group has opportunities to capitalize on the demand for SOFR products and options trading.
Optimism surrounding the company's future growth potential, coupled with effective expense management and revenue diversification, underpin its resilience and strategic outlook.

CME Group excels in Q2 with record revenue and strategic focus

CME Group's Q2 earnings call showcased strong financial performance, driven by growth across asset classes and a focus on customer-centric strategies. The company's emphasis on innovation, regulatory compliance, and market leadership positions it well for future growth.

CME Group reports strong Q3 earnings, eyes growth amid challenges

CME Group's Q3 2023 earnings call highlighted robust financial performance, operational efficiency, and strategic positioning. Despite facing regulatory challenges and cost management concerns, the company remains confident in its offerings and growth prospects. Opportunities for expansion through innovation and capitalizing on market trends were key discussion points.

CME Group achieves record 2023 results amidst global uncertainties

CME Group's record-breaking performance in 2023 underscores its market leadership and financial strength, with revenue growth, margin expansion, and strong product demand driving positive results.
While facing challenges from global uncertainties and market dynamics, the company's strategic focus on innovation, risk management, and efficiency positions it well to capitalize on opportunities in evolving markets.
By introducing new products, expanding partnerships, and navigating changing market conditions adeptly, CME Group demonstrates resilience and adaptability, paving the way for continued growth and success in the financial industry.
Overall, CME Group's strategic initiatives, financial performance, and market positioning reflect a company poised for sustained success, leveraging opportunities and strengths to overcome challenges and drive future growth.

CME Group achieves record earnings in Q1 2024, eyes growth

CME Group delivered a strong performance in Q1 2024, setting records in revenue and earnings.
The company faces challenges in managing expenses amid growth initiatives and competitive dynamics.
However, CME's strengths in market leadership, network infrastructure, and regulatory alignment position it well for future opportunities.
By capitalizing on data services and revenue growth avenues, CME can continue its upward trajectory in the market.

CME Group achieves record Q3 performance amidst regulatory challenges

CME Group's Q3 performance was exceptional, marked by record volumes and financial metrics. Despite challenges in regulatory compliance and competition, the company is well-positioned for growth through strategic opportunities in interest rate products and retail expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

1 Number I'll Be Watching When CME Group Reports Earnings

CME Group (CME) set to launch Micro E-mini Options on Aug 31 to enable hedging of existing equity portfolio positions.

CME Group (CME) Schedules Launch of Micro E-mini Options

CME Group (CME) is poised to grow, given its top-line growth and prudent capital deployment, offset by higher expenses.

Here's Why Investors Should Hold CME Group (CME) Stock Now

CME Group's (CME) average daily volume for June and second-quarter 2020 decreases primarily due to lower volumes across most of its product lines.

CME Group Reports Soft June & Q2 Volumes, Shares Decline

The business model is a 'giant middle-agent' between buyers and sellers, and hedging community.

CME Group - A Good Buy At A Fair Price

CME Group (CME) launches futures contract in partnership with B3 to boost spread treading and hedging mechanism.

CME Group (CME), B3 Partner for Soybean Futures Contract

After a 35% rally off the March bottom, CME Group’s stock seems to have still some room to grow based on its valuation. CME Group’s stock has rallied from $135 to around $178 now, compared to the S&P, which moved over 40%.

Why The Rally In CME Group Stock Isn’t Over Yet

In August, traders will once again be screaming and signalling their business at the Chicago facility.

CME Group Sets Date to Reopen Eurodollar Options Trading Pit

CME Group's (CME) average daily volume of 17.9 million contracts per day in May 2020 was down 25% year over year

CME Group (CME) Reports Soft May Volumes, Shares Decline

CME (CME) reported earnings 30 days ago. What's next for the stock?

CME (CME) Up 1.3% Since Last Earnings Report: Can It Continue?

Beyond Meat

Colgate-Palmolive

Defensive stocks don't have to be stodgy consumer companies.

3 Top Stocks to  Recession-Proof Your Portfolio

Intercontinental Exchange

Let's see how CME Group (CME) and Intercontinental Exchange (ICE) are placed in terms of some of the key metrics.

CME or ICE: Which Exchange Should You Add to Your Portfolio?

CME Group's (CME) units BrokerTec and TriOptima join forces on end-to-end repo workflow solution.

CME Group's (CME) BrokerTec and TriOptima Units Collaborate

The trading platform has seen a frenzy of activity along with the markets. Is that a good sign for the company?

Is CME Group Stock a Buy?

CME Group (CME) unveils options on Micro E-mini S&P 500 and Nasdaq-100 futures contracts to enable hedging of existing equity portfolio positions.

CME Group (CME) to Launch Micro-Sized Options on Futures

CME Group Inc (NASDAQ: CME), the largest financial derivatives exchange, formally announced the launch of options on its Micro E-mini S&P 500 and Micro E-mini Nasdaq 100 futures products.

CME Group Launches Options On Micro E-mini Futures Products

CME Group (CME) is poised to benefit from robust revenues and sound capital position.

Here's Why You Should Add CME Group (CME) to Your Portfolio

Cboe Global Markets

Nasdaq

Lessons learned from the last crash have helped.

4 Fixes That Have Kept the Exchanges From Breaking During the Coronavirus Pandemic

Stocks tied to the various exchanges have reported strong Q1s and may offer some financial sector investing refuge.

Why the Exchanges Could Be a Good Place to Hide During the COVID-19 Crisis

The mercantile exchange operator (and reliable dividend payer) will again hand out $0.85 per share to its investors.

CME Group Declares New Dividend; Yield Is Nearly 2%

Advanced Micro Devices

MarketAxess Holdings

Netflix

ServiceNow

Prologis

Vertex Pharmaceuticals

We’re right in the thick of first-quarter earnings season, and while it is looking bad as consumers and companies suffer from the coronavirus shutdown, there are still companies that are growing rapidly.

Deep Dive: These 10 S&P 500 companies increased sales faster than Amazon in a coronavirus-tainted quarter

Volatility might not be great for investors' nerves, but it's good business for derivatives exchanges.

Is CME Group Stock  a Buy?

CME Group Inc. CME, -2.89% disclosed Thursday that it agreed to an amendment that gives the commodity exchange company a $7 billion multi-currency credit facility.

CME Group secures $7 billion credit facility to protect against a clearing member default

CME (CME) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

All You Need to Know About CME (CME) Rating Upgrade to Buy

CME Group Inc. (CME) CEO Terrence Duffy on Q1 2020 Results - Earnings Call Transcript

News for CME Group Stock (CME)